AZGP1 antibody (AA 22-298)

Catalog No. ABIN513653

The Mouse Polyclonal anti-AZGP1 antibody has been validated for WB. It is suitable to detect AZGP1 in samples from Human. There is 1 publication available.

Quick Overview for AZGP1 antibody (AA 22-298) (ABIN513653)

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Reactivity: Human

Host: Mouse

Clonality: Polyclonal

Conjugate: This AZGP1 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-AZGP1 Antibody

Binding Specificity: AA 22-298

Purpose: Mouse polyclonal antibody raised against a full-length human AZGP1 protein.

Sequence: ENQGGRYSLT YIYTGLSKHV EDVPAFQALG SLNDLQFFRY NSKDRKSQPM GLWRQVEGME DWKQDSQLQK AREDIFMETL KDIVEYYNDS NGSHVLQGRF GCEIENNRSS GAFWKYYYDG KDYIEFNKEI PAWVPFDPAA QITKQKWEAE PVYVQRAKAY LEEECPATLR KYLKYSKNIL DRQDPPSVVV TSHQAPGEKK KLKCLAYDFY PGKIDVHWTR AGEVQEPELR GDVLHNGNGT YQSWVVVAVP PQDTAPYSCH VQHSSLAQPL VGPWEAS

Cross-Reactivity: Human

Characteristics: Antibody reactive against mammalian transfected lysate.

Immunogen: AZGP1 (AAH33830, 22 a.a. ~ 298 a.a) full-length human protein.

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: In 1x PBS, pH 7.4

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

References for anti-AZGP1 antibody (ABIN513653)

Cheng, Wang, Huang, Kao, Lu, Hsiao, Shaw: "Differential proteomics analysis of amniotic fluid in pregnancies of increased nuchal translucency with normal karyotype." in: Prenatal diagnosis, Vol. 31, Issue 3, pp. 274-81, (2011) (PubMed).

Target Details for AZGP1

Target: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Alternative Name: AZGP1

Background: Full Gene Name: alpha-2-glycoprotein 1, zinc-binding
Synonyms: ZA2G,ZAG

Gene ID: 563

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process